Mary H Bach1, Peter A Simkin. 1. Department of Medicine, Division of Rheumatology, University of Washington, Seattle, Washington, USA.
Abstract
PURPOSE OF REVIEW: Although uricosuric agents provide the most time-honoured approach to the control of hyperuricemia, their place in the armamentarium has been eclipsed by that of xanthine oxidase inhibitors. This review considers the potential for uricosuric agents from the perspective of recent progress in the understanding of urate transport systems. RECENT FINDINGS: No new agents have yet become available, but promising new drugs are under development. Better understanding of the transporters URAT1 and ABCG2 in particular would appear to provide opportunities for more selective, better tolerated agents to increase the renal clearance of uric acid and thereby control hyperuricemia. SUMMARY: Conceptually, modest inhibition of renal tubular reabsorption should provide effective relief for the millions of individuals who are now hyperuricemic and who suffer from its principal consequence, gout.
PURPOSE OF REVIEW: Although uricosuric agents provide the most time-honoured approach to the control of hyperuricemia, their place in the armamentarium has been eclipsed by that of xanthine oxidase inhibitors. This review considers the potential for uricosuric agents from the perspective of recent progress in the understanding of urate transport systems. RECENT FINDINGS: No new agents have yet become available, but promising new drugs are under development. Better understanding of the transporters URAT1 and ABCG2 in particular would appear to provide opportunities for more selective, better tolerated agents to increase the renal clearance of uric acid and thereby control hyperuricemia. SUMMARY: Conceptually, modest inhibition of renal tubular reabsorption should provide effective relief for the millions of individuals who are now hyperuricemic and who suffer from its principal consequence, gout.
Authors: Andrew C Nyborg; Chris Ward; Anna Zacco; Benoy Chacko; Luba Grinberg; James C Geoghegan; Ryan Bean; Michaela Wendeler; Frank Bartnik; Ellen O'Connor; Flaviu Gruia; Vidyashankara Iyer; Hui Feng; Varnika Roy; Mark Berge; Jeffrey N Miner; David M Wilson; Dongmei Zhou; Simone Nicholson; Clynn Wilker; Chi Y Wu; Susan Wilson; Lutz Jermutus; Herren Wu; David A Owen; Jane Osbourn; Steven Coats; Manuel Baca Journal: PLoS One Date: 2016-12-21 Impact factor: 3.240
Authors: Nicola Dalbeth; Graeme Jones; Robert Terkeltaub; Dinesh Khanna; Jeff Kopicko; Nihar Bhakta; Scott Adler; Maple Fung; Chris Storgard; Scott Baumgartner; Fernando Perez-Ruiz Journal: Arthritis Rheumatol Date: 2017-08-04 Impact factor: 10.995
Authors: Thomas Bardin; Robert T Keenan; Puja P Khanna; Jeff Kopicko; Maple Fung; Nihar Bhakta; Scott Adler; Chris Storgard; Scott Baumgartner; Alexander So Journal: Ann Rheum Dis Date: 2016-11-07 Impact factor: 19.103